MediFind
Condition

Burkitt Lymphoma

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Burkitt Leukemia
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: Rituximab
  • Number of Patients: 11
  • Published —
This study tested the safety and efficacy of using rituximab to treat patients with Burkitt leukemia.
Latest Advance
Study
  • Condition: Burkitt Lymphoma
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: LMB 89± Rituximab
  • Number of Patients: 43
  • Published —
The study researched the outcomes of treatment with LMB 89± rituximab for Burkitt lymphoma.
Latest Advance
Study
  • Condition: Untreated Burkitt Lymphoma
  • Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Treatment Used: Risk-Adapted Therapy With Dose-Adjusted EPOCH-R
  • Number of Patients: 113
  • Published —
The purpose of the study was to determine the effectiveness of dose-adjusted etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone and rituximab for the treatment of Burkitt lymphoma.
Latest Advance
Study
  • Condition: Burkitt's Lymphoma of Prostate Presenting as Acute Urinary Retention
  • Journal: BMC urology
  • Treatment Used: Chemotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 28-year-old Caucasian male diagnosed with Burkitt's lymphoma of the prostate presenting as acute urinary retention treated with chemotherapy.
Latest Advance
Study
  • Condition: Children with Burkitt Lymphoma
  • Journal: Zhongguo shi yan xue ye xue za zhi
  • Treatment Used: Rituximab
  • Number of Patients: 91
  • Published —
The study researched the outcomes of using Rituximab to treat children with Burkitt lymphoma.
Latest Advance
Study
  • Condition: Progressive or Relapsed Burkitt Lymphoma (BL) or Leukemia in Children and Adolescents
  • Journal: Blood
  • Treatment Used: BFM-Type First-Line Therapy
  • Number of Patients: 157
  • Published —
This study described the characteristics, outcome, re-induction, and transplantation approaches and evaluated risk factors in children with Burkitt lymphoma (BL) or Burkitt leukemia (B-AL) (B-AL).
Latest Advance
Study
  • Condition: Advanced Burkitt Lymphoma (BL) in Sub-Saharan Africa Pediatric Units
  • Journal: Journal of global oncology
  • Treatment Used: Intensive Polychemotherapy Regimen
  • Number of Patients: 400
  • Published —
This study evaluated the results of an intensive polychemotherapy regimen for Burkitt lymphoma (BL) in sub-Saharan African pediatric centers.
Latest Advance
Study
  • Condition: Pediatric high-risk Burkitt lymphoma
  • Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • Treatment Used: LMB89 Group C regimen
  • Number of Patients: 172
  • Published —
The study aimed to determine the effects of LMB89 Group C regimen on pediatric high-risk Burkitt lymphoma.
Latest Advance
Study
  • Condition: Burkitt Lymphoma (BL) and Other High-Grade B-Cell Lymphomas with or without MYC, BCL2, and/or BCL6 Rearrangements
  • Journal: Hematology/oncology clinics of North America
  • Treatment Used: Standard Approaches
  • Number of Patients: 0
  • Published —
This article discusses treatment of Burkitt lymphoma (BL) and other high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements with standard approaches versus novel approaches.
Latest Advance
Study
  • Condition: Children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia
  • Journal: Pediatric blood & cancer
  • Treatment Used: Rituximab
  • Number of Patients: 773
  • Published —
The study researched the outcomes of children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia.
Latest Advance
Study
  • Condition: Mature B-cell Lymphoma in Children and Adolescents
  • Journal: British journal of haematology
  • Treatment Used: Rituximab and Reduced-intensity Chemotherapy
  • Number of Patients: 231
  • Published —
In this study, researchers evaluated the effects of adding rituximab to reduced-intensity chemotherapy for the treatment of mature B-cell lymphoma in children and adolescents.
Latest Advance
Study
  • Condition: B-cell non-Hodgkin lymphoma
  • Journal: International journal of hematology
  • Treatment Used: Hematopoietic stem cell transplantation
  • Number of Patients: 79
  • Published —
This study evaluated the effects of hematopoietic stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.